Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/5098
PMID: 22767144
DOI: 10.1038/bjc.2012.286
ISSN: 0007-0920
Services
Services
Date issued
2012Journal title
BRITISH JOURNAL OF CANCER
Type of content
Artigo
